Related Experiment Video
Updated: Mar 8, 2026
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Late Cardiac Rupture after Amplatzer Septal Occluder Implantation
Insights
Transcatheter device implantation for atrial septal defects can cause rare but life-threatening complications, such as cardiac tamponade. Prompt diagnosis and intervention are crucial for patient safety and managing adverse events.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Technology
Background:
- Transcatheter device implantation is a common alternative to surgical closure for atrial septal defects (ASDs).
- While generally safe, potential early and late complications, some life-threatening, can arise from these procedures.
- Physicians must be aware of these rare but severe adverse events.
Abstract:
Transcatheter device implantation has become an attractive alternative to surgery in the closure of atrial septal defects in selected patients. However, it can lead to early and late sequelae, some of them life threatening. For example, 79 days before her admission to our emergency department with sudden-onset respiratory distress and respiratory arrest (leading to cardiac tamponade and rupture), a 22-year-old woman had undergone percutaneous closure of an atrial septal defect. We describe the damage and its treatment. Although the adverse effects of transcatheter device implantation are rare, physicians should know that these events can be life threatening. Further data are needed to prevent such sequelae and to design new devices. It is of utmost importance that patients and their family members be informed both of possible sequelae and of life-saving interventions to be administered at early diagnosis.
